C A Leissinger
Overview
Explore the profile of C A Leissinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
90
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Valentino L, Allen G, Gill J, Hurlet A, Konkle B, Leissinger C, et al.
Haemophilia
. 2013 Feb;
19(3):e151-66.
PMID: 23374141
In haemophilia patients with well-established high-titer inhibitors, even seemingly minor acute bleeding episodes or surgical procedures may become refractory to treatment and transform into limb- or life-threatening situations. In the...
2.
Goldenberg N, Kruse-Jarres R, Frick N, Pipe S, Leissinger C, Kessler C
Haemophilia
. 2011 Sep;
18(3):326-31.
PMID: 21899663
Successful strategies by which to effectively recruit and retain academic subspecialists in benign haematology have not been established. To evaluate the effectiveness of a grant-funded, mentored fellowship with respect to...
3.
du Treil S, Rice J, Leissinger C
Haemophilia
. 2010 Jan;
16(3):545-7.
PMID: 20050930
No abstract available.
4.
Valentino L, Carcao M, Mathew P, Leissinger C, Berntorp E, Blanchette V, et al.
Haemophilia
. 2009 Mar;
15(4):959-65.
PMID: 19320750
No abstract available.
5.
Kruse-Jarres R, Hadi C, Leissinger C
Haemophilia
. 2007 Nov;
13(6):707-11.
PMID: 17973846
This is the case of a 28-year-old man with severe congenital haemophilia A, who had a relatively mild bleeding course during early childhood, with limited factor VIII (FVIII) exposure. He...
6.
du Treil S, Rice J, Leissinger C
Haemophilia
. 2007 Sep;
13(5):493-501.
PMID: 17880435
It is known that chronically ill patients adhere to medical treatment plans only 50% of the time. Adherence to treatment with factor infusion therapy in haemophilia patients is essential to...
7.
Leissinger C, Becton D, Ewing N, Valentino L
Haemophilia
. 2007 May;
13(3):249-55.
PMID: 17498073
Orthopaedic complications are among the most disabling sequelae occurring in patients with haemophilia and inhibitors. Recurrent or refractory joint bleeds can lead to joint damage, limiting mobility and causing permanent...
8.
Leissinger C
Haemophilia
. 2006 Nov;
12 Suppl 6:67-72.
PMID: 17123397
The presence of high titre inhibitors makes the treatment of bleeding episodes in haemophilia patients difficult and increases the risk of uncontrollable bleeding and disability, despite optimum on-demand treatment with...
9.
Berntorp E, Shapiro A, Astermark J, Blanchette V, Collins P, DiMichele D, et al.
Haemophilia
. 2006 Nov;
12 Suppl 6:1-7.
PMID: 17123387
Participants in an international conference on the management of haemophilia patients with inhibitors developed a jointly authored summary of the findings and conclusions of the conference. Current knowledge of the...
10.
Kruse-Jarres R, Leissinger C
Haemophilia
. 2005 Oct;
11(6):642-3.
PMID: 16236117
No abstract available.